Rifamycin,3-[(1-piperazinylimino)methyl]-

Suppliers

Names

[ CAS No. ]:
13292-45-0

[ Name ]:
Rifamycin,3-[(1-piperazinylimino)methyl]-

[Synonym ]:
4-N-Demethylrifampicin
rifaldehyde piperazin-1-ylhydrazone
Rifampicin AF/AP
3-(piperazin-1-ylimino-methyl)-rifamycin
N-Demethylrifampin
AF/AP
N-Demethylrifampicin
Rifampicin AF/A
3-(piperidinyliminomethyl)rifamycin SV
Demethylrifampicin

Chemical & Physical Properties

[ Density]:
1.35g/cm3

[ Molecular Formula ]:
C42H56N4O12

[ Molecular Weight ]:
808.91400

[ Exact Mass ]:
808.38900

[ PSA ]:
228.94000

[ LogP ]:
4.39790

[ Index of Refraction ]:
1.631

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KD1923000
CHEMICAL NAME :
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b) furan-1,11(2H)-dione, 5,6,9,17,19,21- hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl -8-(N-1-piperazinylfo rmimidoyl)-, 21- acetate
CAS REGISTRY NUMBER :
13292-45-0
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C42-H56-N4-O12
MOLECULAR WEIGHT :
809.02

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
695 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
100 mg/L
REFERENCE :
BBRCA9 Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 60,96,1974

Related Compounds

  • Rifamycin, 3-[(1-pyrrolidinylimino)methyl]-
  • ethyl 3-(1-methyl-4-nitropyrrol-2-yl)prop-2-enoate
  • 1-methyl-3-[(1-methyl-3-piperidyl)oxy]-2H-pyridine
  • acetic acid,3-[1-methyl-2-(4-methylphenyl)sulfanylcyclohex-2-en-1-yl]propan-1-ol
  • 2-methyl-1-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-2-yl]propan-2-amine,dihydrochloride
  • Nicotine N-D-Glucoside
  • ethyl (2Z)-3-(2-methoxy-5-methylphenyl)pent-2-enoate
  • ethyl 2-[(4E)-7-bromo-8-fluoro-3,4-dihydro-2H-1-benzopyran-4-ylidene]acetate
  • 2-{[(5-Chlorofuran-2-yl)methyl]sulfanyl}-6-fluoropyrazine
  • 4-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpropanamido]-1-methyl-1H-pyrazole-5-carboxylic acid
  • 4-[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclobutaneamido]-1-methyl-1H-pyrazole-5-carboxylic acid
  • (2R)-2-({3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexyl}formamido)-4-hydroxybutanoic acid
  • 2-(1-{5-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]oxolane-3-carbonyl}pyrrolidin-3-yl)acetic acid
  • 2-Amino-3-(fluorosulfonyl)benzoic acid
  • Methyl 3-amino-2-(fluorosulfonyl)benzoate
  • 2-Amino-5-methylthiophene-3-sulfonyl fluoride
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.